INPC
INVALIDATION PROCESSED
08/19/2026
Back to search
Official data from USPTO
S SANTONIKA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/19/2026
Trademark type
Combined
Nice classes
5
Filing date
03/30/2017
Registration date
10/30/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2025
Last transaction
08/19/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
LU
Examiner
GOODSAID, IRA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a shield in blue with a snake forming a letter "S" across it in light blue, next to the term, "SANTONIKA" in stylized letters in blue with horizontal bars in letters "A" in light blue.
Holders and representatives
Holders
M. S. (pessoa física)
Representatives
Elena A. Vodyahina
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of brainmental and nervous system disordersvertigocardiovascular issuesstrokesneurodegenerative diseasesinfectionsatherosclerosisattention deficit disorderhyperpiesisneuroticismpsychosomatic diseasesstress disordersasthenic syndromeneurotoxicosis and obesity; veterinary preparations for the treatment of neuroticism and stress disorders; pharmaceuticals and veterinary preparations for use in the treatment of diabetes and complications from diabetesinsulin resistanceinflammation and inflammatory diseasesrespiratory and infectious diseasesnasal congestioncoughsfevercoldsfluimmunological problemsfungal infectionsviral infectionsherpeschicken poxmononucleosishemorrhagic feverencephalitisbacterial infectionspseudotuberculosiswhooping coughyersiniosis and pneumonia; antibacterial preparations; antihistamines; pharmaceutical preparations for the treatment of AIDS and HIV infection; psychotropics; pharmaceutical preparations for the treatment of erectile dysfunctionbenign prostatic hyperplasiaprostatitisdysuric disordersmenopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome and gastrointestinal disorders; anticonvulsants; antianxiety preparations; cough treatment preparations; pharmaceutical preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritisosteoarthrosisarthropathy and ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratorypulmonary and circulatory diseases; antioxidants; pharmaceutical vasoprotective preparations for use in the treatment of blood disordershemorrhoidsvaricose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose and glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention and treatment of mental and neurological disorders and conditions; psychoactive pharmaceutical preparations; anxiolyticsnootropicspsycholepticssedativesantidepressants and neuroleptics; pharmaceutical preparations which stimulate the parasympathetic nervous systemenhance memory functionprevent and alleviate stress and attention deficit disorder; lactose for pharmaceutical purposes; capsules sold empty for pharmaceuticals; vitamin preparations; medical preparations for slimming purposes; nerve calming preparations for medical purposes; appetite suppressant pills
Publications
History of USPTO decisions and trademark events.
35 publications found
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/16/2026
C71T
CANCELLED SECTION 71
05/16/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2019
FIMP
FINAL DISPOSITION PROCESSED
02/07/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2018
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/23/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/13/2018
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
05/24/2018
PUBO
PUBLISHED FOR OPPOSITION
05/15/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/04/2018
NPUB
NOTICE OF PUBLICATION
04/25/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/03/2018
CNEA
EXAMINERS AMENDMENT MAILED
03/22/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2018
RFNT
REFUSAL PROCESSED BY IB
02/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2018
RFRR
REFUSAL PROCESSED BY MPU
01/25/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/18/2018
CNRT
NON-FINAL ACTION WRITTEN
01/17/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
01/17/2018
MAFR
APPLICATION FILING RECEIPT MAILED
01/06/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/03/2018
CNRT
NON-FINAL ACTION WRITTEN
01/02/2018
DOCK
ASSIGNED TO EXAMINER
01/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/29/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/28/2017
Continuous trademark protection
Get notified about every new filing that threatens S SANTONIKA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.